SEPTIN9 and colorectal carcinoma: In the present study, we developed an ultrasensitive methodology (ddPCR) to investigate cfDNA methylation status of SEPT9 and BMP3 in plasma from a series of 262 cases, including normal, precursor lesions and CRC lesions.